On Feb. 26, the House Energy & Commerce Health Subcommittee held a hearing titled: "An Examination of How Reining in PBMs Will Drive Competition and Lower Costs for Patients.“
On February 28, 2025, the Department of Health and Human Services (HHS) issued a Policy on Adhering to the Text of the Administrative Procedure Act (Policy Statement) rescinding a longstanding policy where HHS agencies used full “notice and comment” procedures beyond the minimum circumstances required by the Administrative Procedure Act (APA).
We are less than a month away from AMCP’s annual conference in Houston, Texas, and there are so many great and exciting things to look forward to! We know that the managed care pharmacy landscape is ever-changing, but we also know one thing—that we can shape the future of the industry by working together. So, whether it’s your first conference or you’ve been going for years: there is something for you!
On February 21, 2025, the Centers for Medicare & Medicaid Services (CMS) announced public engagement events for the second cycle of the Medicare Drug Price Negotiation Program.
On February 20, 2025, the Department of Health and Human Services (HHS) Office for Civil Rights (OCR) rescinded prior guidance on gender-affirming care, entitled “HHS Notice and Guidance on Gender Affirming Care, Civil Rights, and Patient Privacy,” issued March 2, 2022 (2022 Guidance).
AMCP encourages schools and colleges of pharmacy to ensure the provision of a balanced, general education, including information regarding emerging technologies and health care systems, to graduate educated and competent health care professionals.